1
|
Horvath V, Svobodova A, Cabral JV, Stadler P, Lindner J, Mrstinova MB, Balogh L, Jirsova K. Cryopreserved amniotic membrane in chronic nonhealing wounds: a series of case reports. Cell Tissue Bank 2024; 25:325-337. [PMID: 37945942 PMCID: PMC10901998 DOI: 10.1007/s10561-023-10100-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/01/2023] [Accepted: 06/19/2023] [Indexed: 11/12/2023]
Abstract
A case series of the use of amniotic membrane (AM) for treating chronic nonhealing wounds. It presents five cases of polymorbid patients with a total of nine chronic nonhealing wounds. The patient group consisted of four men and one woman with various comorbidities, aged 45-72 years. The mean initial wound size was 15.8 cm2, and the mean time from the onset of the wound to the first application of AM was 122 weeks. The wounds were caused by chronic venous insufficiency and/or peripheral arterial disease. Wounds were treated in a standardized protocol. AM was applied weekly in the first month and then every two weeks. Photo documentation of the wound and microbiological colonization was carried out at each visit. In three out of five patients, the AM treatment effectively promoted healing up to complete wound closure. In two cases, the wounds stayed unhealed despite numerous AM applications. Pain relief was noted in all patients. The success of the treatment was closely tied to patient factors, such as adherence to the prescribed treatment regimen and individual patient characteristics. In some cases, treatment failure was observed, possibly due to underlying comorbidities, wound parameters, or poor patient compliance. AM treatment has the potential to become a viable treatment option for these nonhealing wounds. However, the effectiveness of the treatment may be influenced by various patient factors and the underlying cause of the wound. Therefore, it is crucial to have an individualized treatment plan that considers these particular factors.
Collapse
Affiliation(s)
- Vojtech Horvath
- Department of Vascular Surgery, Na Homolce Hospital, Prague, Czech Republic
| | - Alzbeta Svobodova
- 2nd Department of Surgery-Department of Cardiovascular Surgery, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
| | - Joao Victor Cabral
- Department of Obstetrics and Gynaecology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
| | - Petr Stadler
- Department of Vascular Surgery, Na Homolce Hospital, Prague, Czech Republic
| | - Jaroslav Lindner
- 2nd Department of Surgery-Department of Cardiovascular Surgery, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
| | - Miluse Berka Mrstinova
- Department of Obstetrics and Gynaecology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
| | - Lukas Balogh
- Laboratory of Biology and Pathology of the Eye, Institute of Biology and Medical Genetics, 1st Faculty of Medicine and General Teaching Hospital, Charles University, Albertov 4, 128 01, Prague, Czech Republic
| | - Katerina Jirsova
- Laboratory of Biology and Pathology of the Eye, Institute of Biology and Medical Genetics, 1st Faculty of Medicine and General Teaching Hospital, Charles University, Albertov 4, 128 01, Prague, Czech Republic.
- Department of Transplantation and Tissue Bank, Motol University Hospital, Prague, Czech Republic.
| |
Collapse
|
2
|
Horvath V, Svobodova A, Cabral JV, Fiala R, Burkert J, Stadler P, Lindner J, Bednar J, Zemlickova M, Jirsova K. Inter-placental variability is not a major factor affecting the healing efficiency of amniotic membrane when used for treating chronic non-healing wounds. Cell Tissue Bank 2023; 24:779-788. [PMID: 37227562 PMCID: PMC10616215 DOI: 10.1007/s10561-023-10096-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2023] [Accepted: 04/24/2023] [Indexed: 05/26/2023]
Abstract
This study aimed to evaluate the efficacy of cryopreserved amniotic membrane (AM) grafts in chronic wound healing, including the mean percentage of wound closure per one AM application, and to determine whether the healing efficiency differs between AM grafts obtained from different placentas. A retrospective study analyzing inter-placental differences in healing capacity and mean wound closure after the application of 96 AM grafts prepared from nine placentas. Only the placentas from which the AM grafts were applied to patients suffering from long-lasting non-healing wounds successfully healed by AM treatment were included. The data from the rapidly progressing wound-closure phase (p-phase) were analyzed. The mean efficiency for each placenta, expressed as an average of wound area reduction (%) seven days after the AM application (baseline, 100%), was calculated from at least 10 applications. No statistical difference between the nine placentas' efficiency was found in the progressive phase of wound healing. The 7-day average wound reduction in particular placentas varied from 5.70 to 20.99% (median from 1.07 to 17.75) of the baseline. The mean percentage of wound surface reduction of all analyzed defects one week after the application of cryopreserved AM graft was 12.17 ± 20.12% (average ± SD). No significant difference in healing capacity was observed between the nine placentas. The data suggest that if there are intra- and inter-placental differences in AM sheets' healing efficacy, they are overridden by the actual health status of the subject or even the status of its individual wounds.
Collapse
Affiliation(s)
- Vojtech Horvath
- Department of Vascular Surgery, Na Homolce Hospital, Prague, Czech Republic
| | - Alzbeta Svobodova
- 2nd Department of Surgery - Department of Cardiovascular Surgery, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
| | - Joao Victor Cabral
- Laboratory of the Biology and Pathology of the Eye, Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Albertov 4, 128 01, Prague, Czech Republic
| | - Radovan Fiala
- Department of Cardiovascular Surgery, Motol University Hospital, Prague, Czech Republic
| | - Jan Burkert
- Department of Cardiovascular Surgery, Motol University Hospital, Prague, Czech Republic
- Department of Transplantation and Tissue Bank, Motol University Hospital, Prague, Czech Republic
| | - Petr Stadler
- Department of Vascular Surgery, Na Homolce Hospital, Prague, Czech Republic
| | - Jaroslav Lindner
- 2nd Department of Surgery - Department of Cardiovascular Surgery, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
| | - Jan Bednar
- Laboratory of the Biology and Pathology of the Eye, Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Albertov 4, 128 01, Prague, Czech Republic
| | - Martina Zemlickova
- Clinic of Dermatovenerology, General Teaching Hospital and 1st Faculty of Medicine, Charles University, Prague, Czech Republic
| | - Katerina Jirsova
- Laboratory of the Biology and Pathology of the Eye, Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Albertov 4, 128 01, Prague, Czech Republic.
- Department of Transplantation and Tissue Bank, Motol University Hospital, Prague, Czech Republic.
| |
Collapse
|
3
|
Svobodova A, Horvath V, Balogh L, Zemlickova M, Fiala R, Burkert J, Brabec M, Stadler P, Lindner J, Bednar J, Jirsova K. Outcome of Application of Cryopreserved Amniotic Membrane Grafts in the Treatment of Chronic Nonhealing Wounds of Different Origins in Polymorbid Patients: A Prospective Multicenter Study. Bioengineering (Basel) 2023; 10:900. [PMID: 37627785 PMCID: PMC10451957 DOI: 10.3390/bioengineering10080900] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2023] [Revised: 07/25/2023] [Accepted: 07/27/2023] [Indexed: 08/27/2023] Open
Abstract
To compare the therapeutic efficacy of cryopreserved amniotic membrane (AM) grafts and standard of care (SOC) in treating nonhealing wounds (NHW) through a prospective multicenter clinical trial, 42 patients (76% polymorbid) with 54 nonhealing wounds of various etiologies (mainly venous) and an average baseline size of 20 cm2 were included. All patients were treated for at least 6 weeks in the center before they were involved in the study. In the SOC group, 29 patients (36 wounds) were treated. If the wound healed less than 20% of the baseline size after 6 weeks, the patient was transferred to the AM group (35 patients, 43 wounds). Weekly visits included an assessment of the patient's condition, photo documentation, wound debridement, and dressing. Quality of life and the pain degree were subjectively reported by patients. After SOC, 7 wounds were healed completely, 1 defect partially, and 28 defects remained unhealed. AM application led to the complete closure of 24 wounds, partial healing occurred in 10, and 9 remained unhealed. The degree of pain and the quality of life improved significantly in all patients after AM application. This study demonstrates the effectiveness of cryopreserved AM grafts in the healing of NHW of polymorbid patients and associated pain reduction.
Collapse
Affiliation(s)
- Alzbeta Svobodova
- 2nd Department of Surgery—Department of Cardiovascular Surgery, First Faculty of Medicine, Charles University and General University Hospital in Prague, 128 08 Prague, Czech Republic; (A.S.); (J.L.)
| | - Vojtech Horvath
- Department of Vascular Surgery, Na Homolce Hospital, 150 30 Prague, Czech Republic; (V.H.); (P.S.)
| | - Lukas Balogh
- Laboratory of the Biology and Pathology of the Eye, Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, 128 00 Prague, Czech Republic; (L.B.); (J.B.)
| | - Martina Zemlickova
- Clinic of Dermatovenerology, General Teaching Hospital and First Faculty of Medicine, Charles University, 121 08 Prague, Czech Republic;
| | - Radovan Fiala
- Department of Cardiovascular Surgery, Motol University Hospital, 150 06 Prague, Czech Republic; (R.F.); (J.B.)
| | - Jan Burkert
- Department of Cardiovascular Surgery, Motol University Hospital, 150 06 Prague, Czech Republic; (R.F.); (J.B.)
- Department of Transplantation and Tissue Bank, Motol University Hospital, 150 06 Prague, Czech Republic
| | - Marek Brabec
- Department of Statistical Modeling, Institute of Computer Science, The Czech Academy of Sciences, 182 07 Prague, Czech Republic;
| | - Petr Stadler
- Department of Vascular Surgery, Na Homolce Hospital, 150 30 Prague, Czech Republic; (V.H.); (P.S.)
| | - Jaroslav Lindner
- 2nd Department of Surgery—Department of Cardiovascular Surgery, First Faculty of Medicine, Charles University and General University Hospital in Prague, 128 08 Prague, Czech Republic; (A.S.); (J.L.)
| | - Jan Bednar
- Laboratory of the Biology and Pathology of the Eye, Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, 128 00 Prague, Czech Republic; (L.B.); (J.B.)
| | - Katerina Jirsova
- Laboratory of the Biology and Pathology of the Eye, Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, 128 00 Prague, Czech Republic; (L.B.); (J.B.)
- Department of Transplantation and Tissue Bank, Motol University Hospital, 150 06 Prague, Czech Republic
| |
Collapse
|
4
|
Svobodova A, Horvath V, Smeringaiova I, Cabral JV, Zemlickova M, Fiala R, Burkert J, Nemetova D, Stadler P, Lindner J, Bednar J, Jirsova K. The healing dynamics of non-healing wounds using cryo-preserved amniotic membrane. Int Wound J 2021; 19:1243-1252. [PMID: 34791774 PMCID: PMC9284646 DOI: 10.1111/iwj.13719] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/24/2021] [Revised: 10/25/2021] [Accepted: 10/26/2021] [Indexed: 11/28/2022] Open
Abstract
We evaluated the effect of the application of cryo‐preserved amniotic membrane on the healing of 26 non‐healing wounds (18 patients) with varying aetiologies and baseline sizes (average of 15.4 cm2), which had resisted the standard of care treatment for 6 to 456 weeks (average 88.8 weeks). Based on their average general responses to the application of cryo‐preserved AM, we could differentiate three wound groups. The first healed group was characterised by complete healing (100% wound closure, maximum treatment period 38 weeks) and represented 62% of treated wounds. The wound area reduction of at least 50% was reached for all wounds in this group within the first 10 weeks of treatment. Exactly 19% of the studied wounds responded partially to the treatment (partially healed group), reaching less than 25% of closure in the first 10 weeks and 90% at maximum for extended treatment period (up to 78 weeks). The remaining 19% of treated wounds did not show any reaction to the AM application (unhealed defects). The three groups have different profiles of wound area reduction, which can be used as a guideline in predicting the healing prognosis of non‐healing wounds treated with a cryo‐preserved amniotic membrane.
Collapse
Affiliation(s)
- Alzbeta Svobodova
- 2nd Department of Surgery-Department of Cardiovascular Surgery, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
| | - Vojtech Horvath
- Department of Vascular Surgery, Na Homolce Hospital, Prague, Czech Republic
| | - Ingrida Smeringaiova
- Laboratory of the Biology and Pathology of the Eye, Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Prague, Czech Republic
| | - Joao Victor Cabral
- Laboratory of the Biology and Pathology of the Eye, Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Prague, Czech Republic
| | - Martina Zemlickova
- Clinic of Dermatovenerology, General Teaching Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic
| | - Radovan Fiala
- Department of Cardiovascular Surgery, Motol University Hospital, Prague, Czech Republic
| | - Jan Burkert
- Department of Cardiovascular Surgery, Motol University Hospital, Prague, Czech Republic.,Department of Transplantation and Tissue Bank, Motol University Hospital, Prague, Czech Republic
| | - Denisa Nemetova
- Department of Transplantation and Tissue Bank, Motol University Hospital, Prague, Czech Republic
| | - Petr Stadler
- Department of Vascular Surgery, Na Homolce Hospital, Prague, Czech Republic
| | - Jaroslav Lindner
- 2nd Department of Surgery-Department of Cardiovascular Surgery, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
| | - Jan Bednar
- Laboratory of the Biology and Pathology of the Eye, Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Prague, Czech Republic
| | - Katerina Jirsova
- Laboratory of the Biology and Pathology of the Eye, Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Prague, Czech Republic.,Department of Transplantation and Tissue Bank, Motol University Hospital, Prague, Czech Republic
| |
Collapse
|
5
|
Bedanova H, Horvath V, Ondrasek J, Krejci J, Dobsak P, Nemec P. Metformin therapy and risk of cancer in patients after heart transplantation. ACTA ACUST UNITED AC 2021; 122:305-309. [PMID: 33848178 DOI: 10.4149/bll_2021_051] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
BACKGROUND Diabetes mellitus (DM) and malignancy are recognized among the most common complications increasing mortality in patients after heart transplantation (HTx). Clinical trials have shown a higher risk for different types of tumours in diabetic patients. This risk is potentiated by immunosuppressive therapy in transplant patients. Biguanide metformin has been shown to exhibit anti-tumour activity and we tried to find out whether this effect is valid for heart transplant patients. METHODS We retrospectively analysed a group of 497 patients, who undergone HTx in our centre between 1998 and 2019. The primary outcome was any malignancy during the 15-year follow-up period and patient's survival. RESULTS Out of the 497 patients enrolled in the study, 279 (56 %) had diabetes and 52 (19 %) were treated with metformin. Fifteen-year survival in treated patients without malignancy was 93 %, the remainder for the DM patients was 56 %, with survival in non-DM patients being 74 %. Untreated diabetic patients had 4.7 times higher chance of malignancy than those on metformin (p = 0.01). Fifteen-year survival in metformin treated patients was 53 %, in other DM patients 44 %, and in non-DM patients 51 %. CONCLUSION Our study showed a significantly lower incidence of malignancies in metformin-treated patients and slightly better overall survival (Tab. 2, Fig. 3, Ref. 19) Keywords: biguanide, heart graft, malignancy, diabetes mellitus, survival.
Collapse
|
6
|
Szabo L, Bodi V, Czimbalmos CS, Dohy ZS, Horvath V, Toth A, Suhai FI, Geller L, Becker D, Merkely B, Vago H. Diagnostic and prognostic impact of cardiac magnetic resonance, including scar quantification and strain imaging in patients with malignant ventricular arrhythmias and nonobstructed coronary arteries. Eur Heart J Cardiovasc Imaging 2021. [DOI: 10.1093/ehjci/jeaa356.369] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Development and Innovation Fund of Hungary, National Research, Development and Innovation Office
Background
In case of malignant ventricular arrhythmias (VA) and nonobstructed coronary arteries, the differential diagnosis of the underlying diseases is still challenging, due to the board spectrum of possible causes. Cardiac magnetic resonance (CMR) provides functional, morphological and tissue specific information, including necrotic and scar-tissue.
Aims
We aimed to assess the diagnostic and prognostic implications of CMR parameters including global strain values and myocardial scar in patients after ventricular fibrillation (VF) or sustained ventricular tachycardia (SVT) and nonobstructed coronary arteries.
Methods
Between 2011 and 2019, 99 patients (42 ±17 years, 54 male) presenting with VF or SVT and nonobstructed coronary arteries, who underwent CMR examination before secondary prevention implantable cardioverter defibrillator (ICD) implantation were included in our study. Post-processing included feature-tracking strain analysis and left ventricular (LV) scar quantification. Patients were followed for the combined endpoint of all-cause-mortality and appropriate ICD therapy.
Results
CMR examination proved structural myocardial disease in 72%: dilated (n = 21), arrhythmogenic (n = 11), hypertrophic cardiomyopathy (n = 7) and other cardiomyopathies (n = 3). We found LGE patterns showing chronic myocardial infarction (n = 4), suggesting chronic myocarditis (n = 4) and aspecific nonischemic scar formation (n = 14). In 7 cases aspecific structural alterations without scar formation were detected. Overall, myocardial scar was found in 52%, with an average extent of 12 ± 8% of the LV myocardium. The CMR examination changed the clinical diagnosis in 55% of the patients. During a median follow-up at 2 years, 6 patients died and 42 experienced appropriate ICD therapy. We found an association between cardiac events and the presence of structural abnormality and myocardial scar (logrank: 4,553, p < 0.05 and 8.375, p <0.01). On Cox proportional-hazards modell LV ejection fraction, LV stroke volume index, the presence of structural abnormality, the presence and extent of myocardial scar, global LV strain parameters including longitudinal and circumferential strain, and a global left ventricular dssynchrony parameter (mechanical dispersion) were univariate predictors of the combined endpoint of all-cause-mortality and appropriate ICD therapy(p < 0.05).
Conclusion
CMR performed in patients after malignant VA and nonobstructed coronary arteries not only establishes the diagnosis in a high proportion of patients, but may also provide additional prognostic factors. This may indicate that CMR could play a complementary role in the risk stratification in this patient population.
Abstract Figure.
Collapse
Affiliation(s)
- L Szabo
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - V Bodi
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - CS Czimbalmos
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - ZS Dohy
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - V Horvath
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - A Toth
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - FI Suhai
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - L Geller
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - D Becker
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - B Merkely
- Semmelweis University, Faculty of Cardiology and Sports Medicine, Budapest, Hungary
| | - H Vago
- Semmelweis University, Faculty of Cardiology and Sports Medicine, Budapest, Hungary
| |
Collapse
|
7
|
Czimbalmos C, Nardocci C, Deetjen E, Szabo L, Dohy Z, Toth A, Suhai F, Csecs I, Horvath V, Kiss O, Sydo N, Merkely B, Vago H. Differentiation between physiological sport adaptation and hypertrophic cardiomyopathy in highly trained athletes using cardiac magnetic resonance. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.3119] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Differentiation between hypertrophic cardiomyopathy (HCM) patients and healthy athletes (HA) is a common clinical conundrum. We aimed to analyze cardiac magnetic resonance (CMR) characteristics of HA, sedentary HCM and athletic HCM patients and to determine CMR parameters which can help to diagnose HCM in athletes.
Male sedentary HCM patients with slightly elevated maximal end-diastolic wall thickness (EDWT 13–18 mm, n=40, 47.6±14.7y) and HA (n=30, 27.5±5.6y) were consecutively enrolled. Additionally, athletes with HCM were enrolled (n=16, 29.6±13.4 y), where a comprehensive investigation confirmed the diagnosis of HCM. We determined conventional CMR parameters (left ventricular (LV) ejection fraction (EF), end-diastolic (EDVi) and end-systolic volume index, mass index (Mi)), derived parameters such as EDWT/LVEDVi, LVM/LVEDV ratio and strain parameters such as global longitudinal (GLS), radial (GRS) and circumferential strain (GCS), SD of peak LS and CS using feature tracking. Presence of late gadolinium enhancement (LGE) was also determined. CMR parameters representing LV hypertrophy pattern or LV function were analyzed using a logistic regression to detect the best CMR parameters to predict HCM in athletes. To differentiate between HA and athletes with HCM optimal cut-off values for CMR parameters were calculated using receiver operating curve analysis.
Comparing the three groups significant differences were found regarding conventional and derived CMR parameters and strain values. None of the HA showed LGE, 75% of athletic HCM and 82% of sedentary HCM patients showed LGE. The univariate regression model showed that LVEF, EDWT, EDWT/LVMi, LVM/LVEDV, GCS, GRS, SD of peak LS and CS are determinants of the diagnosis of HCM among athletes. Multivariate regression revealed that EDWT/LVMi and GCS are independent disease predictors in athletes (p<0.05).
Cut-off value for GCS ≤−32.5 and for EDWT/LVEDVi >0.126 discriminate athletic HCM from HA with a sensitivity of 81.3 and 87.5% (AUC 0.93), and a specificity of 96.7 and 83.3% (AUC 0.95), respectively (Figure 1).
CMR characteristics of sedentary and athletic HCM may differ, therefore establishing diagnostic parameters based on comparison between athletic HCM and HA is essential. CMR based strain and derived parameters may help to differentiate between physiological and pathological left ventricular hypertrophy in athletes.
Figure 1
Funding Acknowledgement
Type of funding source: Public grant(s) – National budget only. Main funding source(s): National Research, Development and Innovation Office of Hungary (NKFIA) and National Research, Development and Innovation Office (NFKIH) of Hungary.
Collapse
Affiliation(s)
- C Czimbalmos
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - C Nardocci
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - E Deetjen
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - L Szabo
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - Z Dohy
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - A Toth
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - F.I Suhai
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - I Csecs
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - V Horvath
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - O Kiss
- Semmelweis University, Faculty of Cardiology and Sports Medicine, Budapest, Hungary
| | - N Sydo
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - B Merkely
- Semmelweis University, Faculty of Cardiology and Sports Medicine, Budapest, Hungary
| | - H Vago
- Semmelweis University, Faculty of Cardiology and Sports Medicine, Budapest, Hungary
| |
Collapse
|
8
|
Szabo L, Sydo N, Kiss O, Csulak E, Dohy Z, Czimbalmos C, Juhasz V, Horvath V, Suhai F, Merkely B, Vago H. The influence of vigorous training on the structure and cardiorespiratory fitness in adolescent athletes. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.3131] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Introduction
The functional and morphological adaptation of the cardiovascular system to vigorous exercise in adolescents is less understood compared to adult athletes. Therefore, the differential diagnosis of normal cardiovascular adaptation from the possible pathological alterations is challenging. Cardiovascular magnetic resonance is an important method for assessing ventricular function and morphology. Maximal oxygen uptake (VO2 max) has been established as a reliable measure of the maximal ability to produce metabolic power aerobically.
Aims
The aim of this study was to examine left (LV) and right (RV) ventricular morphologic and functional remodeling in elite adolescent athletes using cardiac magnetic resonance imaging (CMR) and cardiopulmonary exercise test (CPET).
Methods
Between 2017 and 2019 116 asymptomatic adolescent (14–20 years) athletes (>6 training hour/week) underwent CMR and CPET as part of a detailed sports cardiology screening. Cine movie images were performed for the quantification of the LV and RV volumes, masses and ejection fraction, and advanced post processing included feature-tracking strain analysis. CPET was performed on a dedicated athlete protocol.
Results
All athletes participated in sports with a high dynamic component. Male athletes (n=74, 16±1 years) demonstrated higher LV and RV end –diastolic volume index (EDVi), stroke volume index (SVi) and mass index (Mi) compared with female athletes (p<0.001). We found significant difference regarding the global circumferential strain (GCS) and mechanical dispersion (MD) of male and female athletes (GCS −34±4 vs. −31±5%; MD 4±2 vs. 7±4% p<0.05). VO2 showed positive correlation with the LV and RV volumetric parameters (EDVi, SVi) and Mi (p<0.001) and the absolute value of GCS (p<0.05), and negative correlation with the MD (p<0.001). In 36 athletes the VO2 max exceeded the age-adjusted expected VO2 max by 130%, which was categorized as excellent. Besides gender, age, and body surface area CMR based LVEDVi and LVMi were independent predictors of VO2 max.
Conclusion
The functional and morphological adaptation of the adolescent cardiovascular system shows noteworthy differences between male and female athletes. VO2 max correlates with several CMR based values including LV and RV volumetric parameters, masses and strain parameters such as GCS and MD.
Strain analysis of an adolescent athlete
Funding Acknowledgement
Type of funding source: Public grant(s) – National budget only. Main funding source(s): Project no. NVKP_16-1-2016-0017 has been implemented with the support provided from the National Research, Development and Innovation Fund of Hungary, financed under the NVKP_16 funding scheme. ÚNKP-19-3-I New National Excellence Program of the Ministry for Innovation and Technology.
Collapse
Affiliation(s)
- L Szabo
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - N Sydo
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - O Kiss
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - E Csulak
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - Z Dohy
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - C Czimbalmos
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - V Juhasz
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - V Horvath
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - F.I Suhai
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - B Merkely
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - H Vago
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| |
Collapse
|
9
|
Szabo L, Bagonyi A, Dohy Z, Czimbalmos C, Toth A, Suhai F, Juhasz V, Horvath V, Becker D, Merkely B, Vago H. Cardiac magnetic resonance features of acute myocarditis presenting as acute coronary syndrome. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.2949] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
Clinical presentation of myocarditis varies, one specific form of myocarditis appears with the clinical signs of acute coronary syndrome (ACS). Cardiac magnetic resonance (CMR) is an important method for assessing ventricular function and morphology, additionally provides accurate tissue specific and functional information of the heart.
Aims
Our aim was to investigate the characteristics, and prognosis of myocarditis presenting with ACS symptoms.
Methods
113 patients with the clinical signs of ACS but nonobstructed coronary arteries in whom the CMR revealed acute myocarditis were included in our study. CMR was performed in acute phase and at 3–6-month follow-up. Left ventricular (LV) volumes, mass and strain parameters expressing myocardial deformity were determined. Additional images were taken to represent tissue specific information. Relationships between laboratory and CMR parameters were investigated. Parameters predicting changes in LV ejection fraction (LVEF) were analyzed by logistic regression.
Results
A total of 113 patients with myocarditis (98 males, 31±11 years) underwent acute and follow-up CMR. Sixty two patients reported fever or infection before the beginning of their complaints, most commonly gastroenteritis (33%) and pharyngitis (32%). The creatinine kinase MB value measured in the acute phase showed positive correlation with the extent of necrosis, and the global longitudinal- and circumferential strain. The extent of the LV necrosis showed negative correlation with LVEF and positive correlation with global circumferential strain (GCS) (p<0.05). On the control CMR examination LVEF and all global strain values improved, fibrosis persisted in 82% of cases but shrank (15±11 vs 5±4 g) and LV mass decreased (p<0.01) compared to the acute phase. Compared to the acute phase, 21% of the patients had lower LVEF on the follow-up CMR. Lower initial LVEF, worse acute GCS, and greater LV necrosis were independent predictors of LVEF reduction in the logistic regression model. During a median follow-up of 6-years of patients treated at our clinic (n=39) no patient suffered cardiac death, heart failure, or documented ventricular arrhythmia but 21% of them had recurrent myocarditis.
Conclusion
Myocarditis mimicking ACS affects predominantly young men and shows functional improvement and good prognosis on follow-up, but it may reoccur in some cases. The reduction of LV function on control CMR may be predicted by worse initial LVEF, GCS, and a larger LV scar.
Strain, LGE in acute phase and follow-up
Funding Acknowledgement
Type of funding source: Public grant(s) – National budget only. Main funding source(s): Project no. NVKP_16-1-2016-0017 has been implemented with the support provided from the National Research, Development and Innovation Fund of Hungary, financed under the NVKP_16 funding scheme. This project was supported by a grant from the National Research, Development and Innovation Office (NKFIH) of Hungary (K 120277).
Collapse
Affiliation(s)
- L Szabo
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - A Bagonyi
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - Z.S Dohy
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - C.S Czimbalmos
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - A Toth
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - F.I Suhai
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - V Juhasz
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - V Horvath
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - D Becker
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - B Merkely
- Semmelweis University, Faculty of Cardiology and Sports Medicine, Budapest, Hungary
| | - H Vago
- Semmelweis University, Faculty of Cardiology and Sports Medicine, Budapest, Hungary
| |
Collapse
|
10
|
Vago H, Szabo L, Dohy Z, Horvath V, Czimbalmos C, Toth A, Suhai F, Skoda R, Barczi G, Becker D, Merkely B. Diagnostic impact of early cardiac magnetic resonance imaging in patients with the working diagnosis of MINOCA. Does the final diagnosis affect patients outcome? Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.1804] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Introduction
The diagnostic value of cardiac magnetic resonance (CMR) imaging has been suggested in determination of the cause in patients with the working diagnosis of Myocardial Infarction with Non-obstructive Coronary Arteries (MINOCA). According to the current STEMI Guideline CMR is considered to have the best diagnostic performance, when CMR timing is within its optimal ≤2 weeks.
Aims
The aim of our study was to assess the diagnostic value of early (1–7 days) CMR examination in patients with signs of troponin positive acute coronary syndrome (ACS) but with nonobstructive coronary arteries. We also aimed to investigate how early CMR changes the provisional diagnosis. We investigated the mortality in each patient group.
Methods
273 consecutive patients (43±16 years, 64% male) with working diagnosis of MINOCA underwent CMR examination following coronary angiography in a mean length of time of 2.5 days between 2009–2020. Cine movie, T2-weighted and late gadolinium enhanced images (LGE) were performed. Left ventricular end-diastolic and end-systolic volumes (LVESVi), ejection fraction (LVEF), mass (LVM) and myocardial necrosis were evaluated. We analysed the risk factors and laboratory values of our patients. Patients were followed for all-cause mortality.
Results
CMR examination established a definitive diagnosis in 86% of the cases: acute myocardial infarction (MI) in 65 patients (47% male), acute myocarditis in 142 patients (87% male), Tako-Tsubo syndrome (TTS) in 27 woman, myocardial contusion in one case. The diagnosis of four patients remained inconclusive after CMR and in 34 pts (50% male) there was no CMR abnormality. CMR changed the provisional diagnosis in 53% of the patients. LVEF was lower, LVESVi was elevated in TTS patients compared to MI and myocarditis (LVEF: 43±9.5 vs 56±7.7 vs 54±6.7%; LVESVi: 52±12.8 vs 38±13.2 vs 42±9.1 ml/m2 p<0.001). Myocarditis patients were younger (myocarditis: 34±10 vs MI 47±14.8 vs TTS 66±10.7 years; p<0.001) and lower percentage had hypercholesterolaemia (myocarditis:18.8 vs MI: 40 vs TTS:54.5%, p<0.01) or hypertension (myocarditis: 20 vs MI: 49 vs TTS: 60%, p<0.001). Laboratory values showed significant elevation of hsTroponin and CKMB of MI and myocarditis patients compared to other groups (p<0.05), but there was no difference between these two groups. During the median follow-up of 3-years 13 patients died. Mortality rate in deaths per patient-year was as follows: MI 2.6 vs Myocarditis 0.4 vs TTS 7.4%. We found a strong association between CMR diagnosis and mortality (logrank 22.3 p<0.001).
Conclusion
Our study demonstrates the diagnostic value of early CMR in patients with the working diagnosis of MINOCA. It established a definite diagnosis in 86% of our patients and changed the provisional diagnosis in 53%. According to our results there is an association between CMR diagnosis and mortality.
Myocarditis, MI, TakoTsubo syndrome
Funding Acknowledgement
Type of funding source: Public grant(s) – National budget only. Main funding source(s): Project no. NVKP_16-1-2016-0017 has been implemented with the support provided from the National Research, Development and Innovation Fund of Hungary, financed under the NVKP_16 funding scheme. This project was supported by a grant from the National Research, Development and Innovation Office (NKFIH) of Hungary (K 120277).
Collapse
Affiliation(s)
- H Vago
- Semmelweis University, Faculty of Cardiology and Sports Medicine, Budapest, Hungary
| | - L Szabo
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - Z Dohy
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - V Horvath
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - C Czimbalmos
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - A Toth
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - F.I Suhai
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - R Skoda
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - G.Y Barczi
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - D Becker
- Semmelweis University Heart and Vascular Center, Budapest, Hungary
| | - B Merkely
- Semmelweis University, Faculty of Cardiology and Sports Medicine, Budapest, Hungary
| |
Collapse
|
11
|
Czimbalmos C, Csecs I, Horvath V, Deetjen E, Nardocci C, Dohy Z, Szabo L, Suhai FI, Toth A, Sydo N, Kiss O, Merkely B, Vago H. P363 Cardiac magnetic resonance characteristics of patients in the grey zone of hypertrophy. Eur Heart J Cardiovasc Imaging 2020. [DOI: 10.1093/ehjci/jez319.212] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Funding Acknowledgements
National Research, Development and Innovation Office (NKFIH) of Hungary (K 120277); Project no. NVKP_16-1-2016-0017. Supported by the ÚNKP-18-3-IV
Background
Differentiation between athlete’s heart and hypertrophic cardiomyopathy (HCM) may cause difficulties especially in patients in the grey zone of hypertrophy.
Purpose
We aimed to analyse cardiac magnetic resonance (CMR) characteristics of healthy athletes, sedentary HCM and athletic HCM patients in the grey zone of hypertrophy.
Methods
Male HCM patients with slightly elevated maximal end-diastolic wall thickness (EDWT 13-18 mm) and highly trained healthy athletes (n = 34, 20.4 ± 2.3 training hrs/week) were consecutively enrolled. HCM patient group was divided to sedentary (n = 35, <7 training hrs/week) and athletic HCM group (n = 13; >7 h/week, 13.2 ± 5.0 h training hrs/week).We determined conventional CMR parameters (left ventricular (LV) ejection fraction (EF),BSA-corrected end-diastolic (EDVi) and end-systolic volume (ESVi), mass (Mi)), derived parameters such as EDWT/LVEDVi, LVM/LVEDV and CMR based strain parameters such as global longitudinal (GLS), radial (GRS) and circumferential strain (GCS), standard deviation of peak LS, RS and CS (SD LS peak, SD RS peak, SD CS peak), standard deviation of time to peak LS, RS and CS (TTP LS, TTP RS, TTP CS) using feature tracking. Presence of late gadolinium enhancement (LGE) was determined on delayed contrast enhanced images. Inter-observer analysis for strain values was performed in a subgroup of 20 patients conducted by two blinded observer.
Results
Healthy athletes showed lower LVEF, GCS and GRS than sedentary and athletic HCM patients, respectively (57.9 ± 5.2 vs 65.3 ± 7.4, 62.7 ± 5.1; -19.7 ± 7.0 vs -24.4 ± 4.6, -22.8 ± 4.8; 61.7 ± 11.2 vs 75.4 ± 21.4, 69.3 ± 19.8). Both healthy athletes and athletes with HCM showed higher LVEDVi, LVESVi, LVSVi and LVMi than sedentary HCM patients. Although sedentary athletes showed higher SD peak strain values and more pronounced intraventricular dyssynchrony than healthy athletes (TTP LS 15.4 ± 4.9 vs 11.7 ± 4.3), none of the global strain values, SD of peak strain values or TTP strain values showed any difference between athletic HCM and healthy athletes. EDWT/LVEDVi ratio was significantly lower in healthy athletes than in sedentary and athletic HCM, respectively (0.11 ± 0.02 vs 0.19±.0.04; 0.18 ± 0.04). Inter-observer analysis showed good agreement in GLS (κ=0.77), GRS (κ=0.69) and TTP LS (κ=0.74), moderate agreement in GCS (κ=0.54), and only fair or poor agreement in SD peak strain, TTP CS and TTP RS values. None of the healthy athletes showed LGE, 62% of athletic HCM and 71% of sedentary HCM patients showed LGE in the hypertrophic segments or in the insertion points.
Conclusions
Based on our results CMR characteristics of sedentary and athletic HCM differs significantly, therefore establishing diagnostic parameters and cut-off values based on comparison between athletic HCM and healthy athletes would be essential. Presence of late gadolinium enhancement and derived parameters may have an important role in the differential diagnosis.
Collapse
Affiliation(s)
- C Czimbalmos
- Semmelweis University Heart Center, Budapest, Hungary
| | - I Csecs
- Semmelweis University Heart Center, Budapest, Hungary
| | - V Horvath
- Semmelweis University Heart Center, Budapest, Hungary
| | - E Deetjen
- Semmelweis University Heart Center, Budapest, Hungary
| | - C Nardocci
- Semmelweis University Heart Center, Budapest, Hungary
| | - Z Dohy
- Semmelweis University Heart Center, Budapest, Hungary
| | - L Szabo
- Semmelweis University Heart Center, Budapest, Hungary
| | - F I Suhai
- Semmelweis University Heart Center, Budapest, Hungary
| | - A Toth
- Semmelweis University Heart Center, Budapest, Hungary
| | - N Sydo
- Semmelweis University Heart Center, Budapest, Hungary
| | - O Kiss
- Semmelweis University Heart Center, Budapest, Hungary
| | - B Merkely
- Semmelweis University Heart Center, Budapest, Hungary
| | - H Vago
- Semmelweis University Heart Center, Budapest, Hungary
| |
Collapse
|
12
|
Czimbalmos C, Csecs I, Dohy Z, Toth A, Suhai F, Szabo L, Horvath V, Sydo N, Kiss O, Becker D, Merkely B, Vago H. P4429Cardiac magnetic resonance characteristics of professional athletes and hypertrophic cardiomyopathy patients in the grey zone of hypertrophy. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz745.0831] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Differentiation between athlete's heart and hypertrophic cardiomyopathy (HCM) may cause difficulties especially in patients in the grey zone of hypertrophy.
We aimed to determine conventional cardiac magnetic resonance (CMR) parameters such as left ventricular (LV) ejection fraction (EF), BSA-corrected end-diastolic (EDVi), end-systolic and stroke volume (SVi), mass (Mi), derived CMR parameters such as maximal end-diastolic wall thickness to LVEDVi ratio (EDWT/LVEDVi), LVM to LVEDV ratio (LVM/LVEDV), and CMR based strain values (global longitudinal (GLS), radial (GRS) and circumferential strain (GCS)) in male HCM patients and athletes.
We consecutively enrolled male HCM patients with only slightly elevated EDWT (13–18 mm) and highly trained healthy athletes (n=30, 18.7±1.2 training hrs/week) with marked LV hypertrophy. HCM patient group was divided into sedentary (n=30, <7 training hrs/week) and athletic HCM group (n=10; >7 h/week, 12.7±7.3 h training hrs/week).
Both sedentary and athletic HCM patients showed higher LVEF, lower LVEDVi and LVESVi and higher EDWT compared to the healthy athletes. LVMi of both healthy athletes and athletic HCM patients was significantly higher than in sedentary HCM patients, respectively (98.9±11.4; 94.5±7.8 vs 78.1±14.4 /m2). EDWT/LVEDVi ratio was higher in both sedentary and athletic HCM patients compared to healthy athletes, respectively (0.19±0.04; 0.17±0.04 vs 0.11±0.02). LVM/LVEDV also showed significant difference between HCM patients and healthy athletes. GLS and GRS showed no significant difference between the three groups, GCS was higher in athletic HCM compared to healthy athletes (−20.7±2.2 vs −17.8±2.3%).
Figure 1. Feature tracking analysis of a healthy athlete and a patient with HCM.
CMR characteristics of athletic and sedentary HCM may fundamentally alter. Our preliminary data suggest that besides conventional CMR parameters, derived parameters such as EDWT/LVEDVi and LVM/LVEDV ratios and deformation imaging may also help the differentiation between pathological and physiological hypertrophy.
Acknowledgement/Funding
National Research, Development and Innovation Office (NKFIH) of Hungary (K 120277). Project no. NVKP_16-1-2016-0017
Collapse
Affiliation(s)
- C Czimbalmos
- Semmelweis University Heart Center, Budapest, Hungary
| | - I Csecs
- Semmelweis University Heart Center, Budapest, Hungary
| | - Z Dohy
- Semmelweis University Heart Center, Budapest, Hungary
| | - A Toth
- Semmelweis University Heart Center, Budapest, Hungary
| | - F Suhai
- Semmelweis University Heart Center, Budapest, Hungary
| | - L Szabo
- Semmelweis University Heart Center, Budapest, Hungary
| | - V Horvath
- Semmelweis University Heart Center, Budapest, Hungary
| | - N Sydo
- Semmelweis University Heart Center, Budapest, Hungary
| | - O Kiss
- Semmelweis University Heart Center, Budapest, Hungary
| | - D Becker
- Semmelweis University Heart Center, Budapest, Hungary
| | - B Merkely
- Semmelweis University Heart Center, Budapest, Hungary
| | - H Vago
- Semmelweis University Heart Center, Budapest, Hungary
| |
Collapse
|
13
|
Vago H, Szabo L, Horvath V, Dohy Z, Czimbalmos C, Toth A, Suhai F, Barczi GY, Becker D, Merkely B. 2388Differential diagnosis of MINOCA patients: the contribution of early cardiac magnetic resonance imaging to the final diagnosis in patients with normal coronary angiography. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz748.0146] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Introduction
The diagnostic value of cardiac magnetic resonance (CMR) imaging has been suggested in determination of the cause behind Myocardial Infarction with Non-obstructive Coronary Arteries (MINOCA). According to the current STEMI Guideline CMR is considered to have the best diagnostic performance, when CMR timing is within its optimal ≤2 weeks.
Purpose
The aim of our study was to establish the prevalence of the underlying pathologies using early (1–7 days) CMR examination in patients with signs of troponin positive acute coronary syndrome (ACS) but normal coronary angiography (NCA). We also aimed to investigate how early CMR changes the provisional diagnosis, and to provide detailed information of CMR characteristics of our pts and to compare laboratory parameters and risk factors of each group.
Methods
Between 2010–2018 (n=234) consecutive pts (40.2±12.1y, 159 male) with troponin positive ACS underwent CMR examination following NCA (≤20% stenosis), in a mean length of time of 2.5 days. Cine movie, T2-weighted and late gadolinium enhanced images (LGE) were performed. Left ventricular end-diastolic and end-systolic volumes (LVESVi), ejection fraction (LVEF), mass (LVM) and myocardial necrosis were evaluated. We analysed the risk factors and laboratory values of our patients.
Results
CMR proved acute myocardial infarction (MI) in 42 pts (52% male), acute myocarditis in 138 pts (89% male), Tako-Tsubo cardiomyopathy (TTC) in 25 woman, myocardial contusion in one case, in three cases CMR raised the suspicion of sarcoidosis and in 25 pts (56% male) there was no CMR abnormality. LVEF was lower, LVESVi was elevated in TTC patients compared to MI and myocarditis (LVEF: 44±9.1 vs 56.5±7 vs 55±6.6%; LVESVi: 52.5±12.9 vs 41±16.8 vs 42.1±8.9 ml/m2 p<0.001). The most frequently affected areas of the myocardium by LGE were the basal and mid inferolateral segments in case of myocarditis (69% of pts). In MI pts the anterior wall was affected only in 16%, while the involvement of inferior wall was visible in 57% of the pts. Early CMR examination established a definitive diagnosis in 88% of the cases, in 11% there was no CMR abnormality and it remained inconclusive in only 1% of the cases. CMR changed the provisional diagnosis in 47% of the pts.
Myocarditis pts were younger (myocarditis: 32.5±10.8 vs MI 47.6±15.5 vs TTC 65.5±9.6 y; p<0.001) and lower percentage had hypercholesterinaemia (myocarditis: 18.8 vs MI: 40 vs TTC: 54.5%, p<0.01) or hypertension (myocarditis: 14.3 vs MI: 38.7 vs TTC: 55.6%, p<0.001). Laboratory values showed significant elevation of hsTroponin and CKMB of MI and myocarditis pts compared to other groups (p<0.05), but there was no difference between these two groups.
Underlying pathologies in MINOCA
Conclusion
In patients with the working diagnosis of MINOCA and normal coronary angiography early CMR established a definitive diagnosis in 88% of our patients and changed the provisional diagnosis in 47% of the pts.
Acknowledgement/Funding
Project no. NVKP_16-1-2016-0017 has been implemented with the support provided from the National Research, Development and Innovation Fund of Hungary
Collapse
Affiliation(s)
- H Vago
- Heart and Vascular Center Senmelweis University, Budapest, Hungary
| | - L Szabo
- Heart and Vascular Center Senmelweis University, Budapest, Hungary
| | - V Horvath
- Heart and Vascular Center Senmelweis University, Budapest, Hungary
| | - Z Dohy
- Heart and Vascular Center Senmelweis University, Budapest, Hungary
| | - C Czimbalmos
- Heart and Vascular Center Senmelweis University, Budapest, Hungary
| | - A Toth
- Heart and Vascular Center Senmelweis University, Budapest, Hungary
| | - F Suhai
- Heart and Vascular Center Senmelweis University, Budapest, Hungary
| | - G Y Barczi
- Heart and Vascular Center Senmelweis University, Budapest, Hungary
| | - D Becker
- Heart and Vascular Center Senmelweis University, Budapest, Hungary
| | - B Merkely
- Heart and Vascular Center Senmelweis University, Budapest, Hungary
| |
Collapse
|
14
|
Szabo L, Horvath V, Dohy Z, Czimbalmos C, Toth A, Suhai F, Barczi G, Becker D, Merkely B, Vago H. P876Cardiac magnetic resonance based feature-tracking myocardial strain analysis in MINOCA patients. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz747.0473] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
The diagnostic performance of cardiac magnetic resonance (CMR) based deformation imaging (feature tracking - FT) has been demonstrated in various groups of patients including acute myocardial infarction and acute myocarditis. However, the capability of this method to distinguish between patients with the working diagnosis of MINOCA is yet to be tested.
We aimed to compare standard CMR parameters and investigate the differential diagnostic value of CMR-FT myocardial strain in pts with the working diagnosis of MINOCA.
From our consecutive register of pts with troponin positive acute coronary syndrome (n=234 pts) we enrolled 100 pts (47.7±14 y; 51 male) in this study.Twenty-five pts were selected randomly from each group of acute myocardial infarction (MI), acute myocarditis, Tako-Tsubo cardiomyopathy (TTC) and pts without structural alteration on CMR, and an additional group of healthy control (n=20, 46±8.2 y; 12 male). Standard CMR parameters such as left ventricular ejection fraction (LVEF), end-diastolic (LVEDVi) and end-systolic (LVESVi) volumes, myocardial mass were assessed and compared between the groups. We performed CMR-FT analysis of the left ventricle, including: global longitudinal (GLS), circumferential (GCS), standard deviation (SD) of the peak circumferential (CS) strain furthermore mechanical dispersion (MD), defined as the SD of the time-to-peak circumferential (MDC) strain of the LV segments expressed as percent of the cardiac cycle.
LVEF was lower (44±9.1%) and LVESVi (52.5±12.9ml/m2) was higher in TTC pts compared to all other groups (p<0.001). The LVEF, LVEDVi and LVESVi parameters did not show significant difference between MI and myocarditis pts (LVEF 56.5±7% vs 55±6.6%; LVEDVi 85.4±14.8 vs 92.7±10.7ml/m2; LVESVi 37.7±11.4 vs 41.5±9.1ml/m2). GLS and GRS were significantly reduced in TTC pts (−11.4±4.8%; 43.09±12.5%) compared to all other groups (p<0.001). GCS was impaired in pts with TTC, acute myocarditis and MI compared to healthy controls (−14±3.7 vs −18.7±3.7 vs −19.1±3.8 vs −23.2±3.1%, p<0.001), however there was no significant difference between myocarditis and MI pts. SD of the peak CS was lower in myocarditis compared to other groups (p<0.001). MDC was elevated in TTC and MI compared to myocarditis and healthy controls (16.3±5 vs 13.3±3.4 vs 8.1±3.3 vs 9.46±3.5% p<0.05). There was no significant difference between healthy controls and patients without structural alterations in any strain parameter.
Strain analysis of a TTC patient
Feature tracking analysis may enable differentiation between patients with MINOCA. TTC reduces global myocardial strain of the left ventricle and causes regional heterogeneity of the left ventricular contraction. Although standard volumetric CMR parameters and CMR based global strain values have limited capability to distinguish between MI and myocarditis with preserved ejection fraction, regional heterogeneity, expressible in MDC is significantly elevated in MI compared to myocarditis and healthy controls.
Acknowledgement/Funding
Project no. NVKP_16-1-2016-0017 has been implemented with the support provided from the National Research, Development and Innovation Fund of Hungary
Collapse
Affiliation(s)
- L Szabo
- Semmelweis University Heart Center, Budapest, Hungary
| | - V Horvath
- Semmelweis University Heart Center, Budapest, Hungary
| | - Z Dohy
- Semmelweis University Heart Center, Budapest, Hungary
| | - C Czimbalmos
- Semmelweis University Heart Center, Budapest, Hungary
| | - A Toth
- Semmelweis University Heart Center, Budapest, Hungary
| | - F Suhai
- Semmelweis University Heart Center, Budapest, Hungary
| | - G Barczi
- Semmelweis University Heart Center, Budapest, Hungary
| | - D Becker
- Semmelweis University Heart Center, Budapest, Hungary
| | - B Merkely
- Semmelweis University Heart Center, Budapest, Hungary
| | - H Vago
- Semmelweis University Heart Center, Budapest, Hungary
| |
Collapse
|
15
|
Vago H, Dohy Z, Czimbalmos C, Szabo L, Horvath V, Tarjanyi Z, Szakal-Toth Z, Parazs N, Toth A, Suhai F, Edes I, Becker D, Sax B, Merkely B. P3558Cardiac magnetic resonance characteristics of the transplanted heart: first results of the prospective Heart-TIming CMR substudy. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz745.0421] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
In case of heart transplantation (HTX) the heart is affected by several factors e.g. ischaemia/reperfusion, denervation, immunosuppression. During the adaptation, the heart may show marked temporal changes in terms of myocardial mechanics, function and tissue characteristics. To better understand temporal characteristics after orthotopic bicaval HTX we started the prospective Heart-TIming (Transplantation Imaging) trial in January 2018 including standard 12-lead ECG, 24-hour Holter monitor, endomyocardial biopsy, transthoracic echocardiography, invasive coronary angiography with intravascular ultrasound and optical coherence tomography and cardiac magnetic resonance (CMR).
Aim
In our CMR substudy we aimed to evaluate the physiological structural and functional left and right ventricular characteristics and their temporal changes after HTX using CMR.
Methods
As part of the study HTX patients underwent CMR at 1, 3 and 6 months after HTX (n=31; 52±10.5y, 25 male). Cine images, T2-weighted, late gadolinium enhancement (LGE) and adenosine stress perfusion (at 1 month) images were acquired. In order to describe physiological characteristics of the transplanted heart we excluded pts with significant coronary artery disease, ischaemic scar, ≥Grade II allograft rejection from this present study (n=6). We assessed the left (LV) and right ventricular (RV) ejection fractions, volumes, masses (M) and LV strain. We assessed the global strain values: longitudinal, circumferential (GCS) strain and the standard deviation (SD) of the peak longitudinal strain (LS) and the left ventricular mechanical dispersion. We compared baseline volumetric and strain parameters to age matched healthy controls (n=20; 47±11.4y, 15 male), and the temporal changes between one, three and 6 months.
Results
Comparing the HTX patients' CMR parameters at one month with normal controls, HTX patients had lower LV and RV end-diastolic volumes (LVEDVi: 76.6±15.9 vs 90.6±11.6ml/m2; RVEDVi 74.5±17.5 vs 90.3±12.1ml/m2, p<0.05),stroke volumes (p<0.05) and higher LVMi (67.6±14.4 vs 57.2±11g/m2, p<0.05). CMR based strain analysis of the HTX pts showed hyperkinetic GCS (−40,5±6.3% vs −35.2±4.8%, p<0.05), increased SD of peak LS and more pronounced mechanical dispersion (p<0.001) compared to the controls. Examining temporal changes in HTX pts we found a decrease in LVMi (69.57±16.4 vs 61.7±9.8g/m2, p<0.05) already at three months, normalization of GCS (−37.7±5.5% vs −32.6±4.9%, p<0.05) and decrease in SD of peak LS (13.5±2.3 vs 11.4±2.4, p<0.05) at 6 months. Oedema was present in all pts at one month after HTX, and disappeared after three months. LGE with aspecific pattern was present in 42%.
LGE with aspecific pattern in HTX pts
Conclusions
Understanding the temporal changes of LV mechanics, function and tissue characteristics, furthermore the establishment of physiological values may help in the early, noninvasive identification of pathological changes in HTX pts.
NCT number: NCT03499197
Acknowledgement/Funding
Project no. NVKP_16-1-2016-0017 has been implemented with the support provided from the National Research, Development and Innovation Fund of Hungary
Collapse
Affiliation(s)
- H Vago
- Heart and Vascular Center Senmelweis University, Budapest, Hungary
| | - Z Dohy
- Heart and Vascular Center Senmelweis University, Budapest, Hungary
| | - C Czimbalmos
- Heart and Vascular Center Senmelweis University, Budapest, Hungary
| | - L Szabo
- Heart and Vascular Center Senmelweis University, Budapest, Hungary
| | - V Horvath
- Heart and Vascular Center Senmelweis University, Budapest, Hungary
| | - Z Tarjanyi
- Heart and Vascular Center Senmelweis University, Budapest, Hungary
| | - Z Szakal-Toth
- Heart and Vascular Center Senmelweis University, Budapest, Hungary
| | - N Parazs
- Heart and Vascular Center Senmelweis University, Budapest, Hungary
| | - A Toth
- Heart and Vascular Center Senmelweis University, Budapest, Hungary
| | - F Suhai
- Heart and Vascular Center Senmelweis University, Budapest, Hungary
| | - I Edes
- Heart and Vascular Center Senmelweis University, Budapest, Hungary
| | - D Becker
- Heart and Vascular Center Senmelweis University, Budapest, Hungary
| | - B Sax
- Heart and Vascular Center Senmelweis University, Budapest, Hungary
| | - B Merkely
- Heart and Vascular Center Senmelweis University, Budapest, Hungary
| |
Collapse
|
16
|
Schmitto J, Dogan G, Hanke S, Riebandt J, Ozbaran M, Engin C, Kervan U, Paç M, Horvath V, Klotz S, Wagner F, Roussel C, Shrestha M, Feldmann C, Chatterjee A, Martens A, Zimpfer D. A Multicenter Analysis of Implantation via a Thoracotomy Approach of a Left Ventricular Assist System for the Treatment of Advanced Heart Failure. Thorac Cardiovasc Surg 2019. [DOI: 10.1055/s-0039-1678824] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Affiliation(s)
- J. Schmitto
- Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany
| | - G. Dogan
- Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany
| | - S. Hanke
- Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany
| | - J. Riebandt
- Division of Cardiac Surgery, Department of Surgery, Medical University of Vienna, Vienna, Austria
| | - M. Ozbaran
- Department of Cardiovasculary Surgery, Ege University School of Medicine, Izmir, Turkey
| | - C. Engin
- Department of Cardiovasculary Surgery, Ege University School of Medicine, Izmir, Turkey
| | - U. Kervan
- Department of Heart Transplantation, Turkiye Yuksek Ihtisas Training and Research Hospital, Ankara, Turkey
| | - M. Paç
- Department of Heart Transplantation, Turkiye Yuksek Ihtisas Training and Research Hospital, Ankara, Turkey
| | - V. Horvath
- Center of Cardiovascular and Transplant Surgery, Brno, Czech Republic
| | - S. Klotz
- Department of Cardiac and Thoracic Vascular Surgery, University Hospital of Luebeck, Luebeck, Germany
| | - F. Wagner
- Department of Cardiac Surgery, Asklepios Clinic St. Georg, Hamburg, Germany
| | - C. Roussel
- Department of Thoracic and CardioVascular Surgery, Nantes Hospital University, Saint-Herblain, France
| | - M. Shrestha
- Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany
| | - C. Feldmann
- Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany
| | - A. Chatterjee
- Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany
| | - A. Martens
- Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany
| | - D. Zimpfer
- Division of Cardiac Surgery, Department of Surgery, Medical University of Vienna, Vienna, Austria
| |
Collapse
|
17
|
Schmitto D, Dogan G, Hanke S, Riebandt J, Ozbaran M, Engin C, Kervan U, Paç M, Horvath V, Klotz S, Wagner F, Roussel C, Shrestha M, Feldmann C, Chatterjee A, Martens A, Zimpfer D. Alternative Outflow Graft Placement during Thoracotomy Implant of the HVAD System for the Treatment of Advanced Heart Failure. Thorac Cardiovasc Surg 2019. [DOI: 10.1055/s-0039-1679026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Affiliation(s)
- D. Schmitto
- Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany
| | - G. Dogan
- Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany
| | - S. Hanke
- Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany
| | - J. Riebandt
- Division of Cardiac Surgery, Department of Surgery, Medical University of Vienna, Vienna, Austria
| | - M. Ozbaran
- Department of Cardiovascular Surgery, Ege University School of Medicine, Izmir, Turkey
| | - C. Engin
- Department of Cardiovascular Surgery, Ege University School of Medicine, Izmir, Turkey
| | - U. Kervan
- Department of Heart Transplantation, Turkiye Yuksek Ihtisas Training and Research Hospital, Ankara, Turkey
| | - M. Paç
- Department of Heart Transplantation, Turkiye Yuksek Ihtisas Training and Research Hospital, Ankara, Turkey
| | - V. Horvath
- Center of Cardiovascular and Transplant Surgery, Brno, Czech Republic
| | - S. Klotz
- Department of Cardiac and Thoracic Vascular Surgery, University Hospital of Luebeck, Lübeck, Germany
| | - F. Wagner
- Department of Cardiac Surgery, Asklepios Clinic St. Georg, Hamburg, Germany
| | - C. Roussel
- Department of Thoracic and Cardiovascular Surgery, Nantes Hospital University, Saint-Herblain, France
| | - M. Shrestha
- Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany
| | - C. Feldmann
- Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany
| | - A. Chatterjee
- Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany
| | - A. Martens
- Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany
| | - D. Zimpfer
- Division of Cardiac Surgery, Department of Surgery, Medical University of Vienna, Vienna, Austria
| |
Collapse
|
18
|
Zimpfer D, Schmitto J, Horvath V, Klotz S, Kervan U, Pac M, Roussel J. Alternative Outflow Graft Placement During Thoracotomy Implant of the HVAD System for the Treatment of Advanced Heart Failure. J Heart Lung Transplant 2018. [DOI: 10.1016/j.healun.2018.01.354] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
19
|
Kral‐Pointner JB, Schrottmaier WC, Horvath V, Datler H, Hell L, Ay C, Niederreiter B, Jilma B, Schmid JA, Assinger A, Mackman N, Knapp S, Schabbauer G. Myeloid but not epithelial tissue factor exerts protective anti-inflammatory effects in acid aspiration-induced acute lung injury. J Thromb Haemost 2017; 15:1625-1639. [PMID: 28509332 PMCID: PMC5575489 DOI: 10.1111/jth.13737] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2016] [Indexed: 01/11/2023]
Abstract
Essentials Tissue factor (TF) represents a central link between hemostasis and inflammation. We studied the roles of myeloid and airway epithelial TF in acid-caused acute lung injury (ALI). TF on myeloid cells displays a non-coagulatory role regulating the inflammatory response in ALI. Airway epithelial TF contributes to hemostatic functions, but is dispensable in ALI pathogenesis. SUMMARY Introduction Acute lung injury (ALI) is a life-threatening condition characterized by damaged alveolar-capillary structures and activation of inflammatory and hemostatic processes. Tissue factor (TF) represents a crucial link between inflammation and coagulation, as inflammatory mediators induce myeloid TF expression, and TF initiates extrinsic coagulation. Objective As pulmonary inflammation stimulates TF expression and TF modulates immune responses, we aimed to elucidate its impact on ALI. In particular, we wanted to distinguish the contributions of TF expressed on airway epithelial cells and TF expressed on myeloid cells. Methods Mice with different cell type-specific TF deficiency and wild-type littermates were intratracheally treated with hydrochloric acid, and leukocyte recruitment, cytokine levels, thrombin-antithrombin (TAT) complexes and pulmonary protein-rich infiltrates were analyzed. Results Our data demonstrate that a lack of epithelial TF did not influence acute responses, as bronchoalveolar neutrophil accumulation 8 h after ALI induction was unaltered. However, it led to mild, prolonged inflammation, as pulmonary leukocyte and erythrocyte numbers were still increased after 24 h, whereas those in wild-type mice had returned to basal levels. In contrast, myeloid TF was primarily involved in regulating the acute phase of ALI without affecting local coagulation, as indicated by increased bronchoalveolar neutrophil infiltration, pulmonary interleukin-6 levels, and edema formation, but equal TAT complex formation, 8 h after ALI induction. This augmented inflammatory response associated with myeloid TF deficiency was confirmed in vitro, as lipopolysaccharide-stimulated TF-deficient alveolar macrophages released increased levels of chemokine (C-X-C motif) ligand 1 and tumor necrosis factor-α as compared with wild-type macrophages. Conclusion We conclude that myeloid TF dampens inflammation in acid-induced ALI.
Collapse
Affiliation(s)
- J. B. Kral‐Pointner
- Institute for PhysiologyCenter for Physiology and PharmacologyMedical University of ViennaViennaAustria
| | - W. C. Schrottmaier
- Institute for PhysiologyCenter for Physiology and PharmacologyMedical University of ViennaViennaAustria
| | - V. Horvath
- Institute for PhysiologyCenter for Physiology and PharmacologyMedical University of ViennaViennaAustria
| | - H. Datler
- Institute for PhysiologyCenter for Physiology and PharmacologyMedical University of ViennaViennaAustria
| | - L. Hell
- Clinical Division of Hematology and HemostaseologyDepartment of Medicine IMedical University of ViennaViennaAustria
| | - C. Ay
- Clinical Division of Hematology and HemostaseologyDepartment of Medicine IMedical University of ViennaViennaAustria
| | - B. Niederreiter
- Division of RheumatologyInternal Medicine IIIMedical University of ViennaViennaAustria
| | - B. Jilma
- Departments of Clinical PharmacologyDepartment of Medicine IMedical University of ViennaViennaAustria
| | - J. A. Schmid
- Department for Vascular Biology and Thrombosis ResearchCenter for Physiology and PharmacologyMedical University of ViennaViennaAustria
| | - A. Assinger
- Institute for PhysiologyCenter for Physiology and PharmacologyMedical University of ViennaViennaAustria
| | - N. Mackman
- Division of Hematology/Oncology, Thrombosis and Hemostasis ProgramUNC McAllister Heart InstituteUniversity of North CarolinaChapel HillNCUSA
| | - S. Knapp
- CEMMResearch Center for Molecular Medicine of the Austrian Academy of SciencesViennaAustria
- Laboratory of Infection BiologyDepartment of Medicine IMedical University of ViennaViennaAustria
| | - G. Schabbauer
- Institute for PhysiologyCenter for Physiology and PharmacologyMedical University of ViennaViennaAustria
| |
Collapse
|
20
|
Bedanova H, Fila P, Horvath V, Sebo M, Podrouzkova H, Orban M, Nemec P. Association between the heart rate early after heart transplantation and the long term clinical outcomes. ACTA ACUST UNITED AC 2017; 118:366-369. [PMID: 28664747 DOI: 10.4149/bll_2017_069] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
BACKGROUND A strong correlation between a lower heart rate and survival has been demonstrated in various patient populations. The optimal heart rate for heart transplant patients is still unknown. The aim of our study was to evaluate the association between an early heart rate and survival after heart transplantation. MATERIAL AND METHODS We retrospectively analysed a group of 330 patients, who underwent heart transplantation in our institution from 1994 to 2014 and complete datasets, including 24-hour heart rate monitoring one month after the heart transplantation. Patients were divided in 2 groups: Group A (n = 278) with the average 24-hour heart rate <90 bpm, and Group B (n = 52) with ≥ 90 bpm. RESULTS The average period of monitoring was 7.5 ± 5.3 years. No differences in baseline characteristics were observed in both groups of recipients and respective donors. One-year survival in groups A and B was 92 % and 81 %, respectively; 5-year survival was 79 % and 60 %, respectively; and 10-year survival was 66 % and 50 %, respectively (p = 0.001). CONCLUSION Increased heart rate in the early post-transplant period was significantly associated with a poorer survival rate in patients after heart transplantation (Tab. 2, Fig. 1, Ref. 25).
Collapse
|
21
|
Knappett PSK, Du J, Liu P, Horvath V, Mailloux BJ, Feighery J, van Geen A, Culligan PJ. Importance of Reversible Attachment in Predicting E. Coli Transport in Saturated Aquifers From Column Experiments. Adv Water Resour 2014; 63:120-130. [PMID: 24821993 PMCID: PMC4014781 DOI: 10.1016/j.advwatres.2013.11.005] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
Drinking water wells indiscriminatingly placed adjacent to fecal contaminated surface water represents a significant but difficult to quantify health risk. Here we seek to understand mechanisms that limit the contamination extent by scaling up bacterial transport results from the laboratory to the field in a well constrained setting. Three pulses of E. coli originating during the early monsoon from a freshly excavated pond receiving latrine effluent in Bangladesh were monitored in 6 wells and modeled with a two-dimensional (2-D) flow and transport model conditioned with measured hydraulic heads. The modeling was performed assuming three different modes of interaction of E. coli with aquifer sands: 1) irreversible attachment only (best-fit ki=7.6 day-1); 2) reversible attachment only (ka=10.5 and kd=0.2 day-1); and 3) a combination of reversible and irreversible modes of attachment (ka=60, kd=7.6, ki=5.2 day-1). Only the third approach adequately reproduced the observed temporal and spatial distribution of E. coli, including a 4-log10 lateral removal distance of ∼9 m. In saturated column experiments, carried out using aquifer sand from the field site, a combination of reversible and irreversible attachment was also required to reproduce the observed breakthrough curves and E. coli retention profiles within the laboratory columns. Applying the laboratory-measured kinetic parameters to the 2-D calibrated flow model of the field site underestimates the observed 4-log10 lateral removal distance by less than a factor of two. This is promising for predicting field scale transport from laboratory experiments.
Collapse
Affiliation(s)
- P. S. K. Knappett
- Lamont-Doherty Earth Observatory of Columbia University, Palisades, NY 10964
| | - J. Du
- Civil Engineering and Engineering Mechanics, Columbia University, New York, NY 10027
| | - P. Liu
- Civil Engineering and Engineering Mechanics, Columbia University, New York, NY 10027
| | - V. Horvath
- Department of Environmental Science, Barnard College, New York, NY 10027
| | - B. J. Mailloux
- Department of Environmental Science, Barnard College, New York, NY 10027
| | - J. Feighery
- Civil Engineering and Engineering Mechanics, Columbia University, New York, NY 10027
| | - A. van Geen
- Lamont-Doherty Earth Observatory of Columbia University, Palisades, NY 10964
| | - P. J. Culligan
- Civil Engineering and Engineering Mechanics, Columbia University, New York, NY 10027
| |
Collapse
|
22
|
Horvath V, Nemec P, Ondrasek J, Bedanova H, Slavik J, Pokorny P, Pavlik P, Orban M. Biventricular centrimag support for patients in end-stage biventricular heart failure. J Cardiothorac Surg 2013. [PMCID: PMC3892168 DOI: 10.1186/1749-8090-8-s1-o146] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|
23
|
Lankeit M, Lukasz A, Niemann C, Horvath V, Dellas C, Pavenstaedt HJ, Kuempers P, Konstantinides S. Angiopoietin-2 - a novel biomarker for risk stratification of acute pulmonary embolism. Eur Heart J 2013. [DOI: 10.1093/eurheartj/eht308.p1144] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
24
|
Vondalova Blanarova O, Jelinkova I, Szoor A, Skender B, Soucek K, Horvath V, Vaculova A, Andera L, Sova P, Szollosi J, Hofmanova J, Vereb G, Kozubik A. Cisplatin and a potent platinum(IV) complex-mediated enhancement of TRAIL-induced cancer cells killing is associated with modulation of upstream events in the extrinsic apoptotic pathway. Carcinogenesis 2010; 32:42-51. [DOI: 10.1093/carcin/bgq220] [Citation(s) in RCA: 36] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
25
|
Bryja V, Pacherník J, Vondráček J, Souček K, Čajánek L, Horvath V, Holubcová Z, Dvořák P, Hampl A. Lineage specific composition of cyclin D-CDK4/CDK6-p27 complexes reveals distinct functions of CDK4, CDK6 and individual D-type cyclins in differentiating cells of embryonic origin. Cell Prolif 2008; 41:875-893. [PMID: 19040567 PMCID: PMC2659368 DOI: 10.1111/j.1365-2184.2008.00556.x] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022] Open
Abstract
Abstract. Objectives: This article is to study the role of G1/S regulators in differentiation of pluripotent embryonic cells. Materials and methods: We established a P19 embryonal carcinoma cell‐based experimental system, which profits from two similar differentiation protocols producing endodermal or neuroectodermal lineages. The levels, mutual interactions, activities, and localization of G1/S regulators were analysed with respect to growth and differentiation parameters of the cells. Results and Conclusions: We demonstrate that proliferation parameters of differentiating cells correlate with the activity and structure of cyclin A/E–CDK2 but not of cyclin D–CDK4/6–p27 complexes. In an exponentially growing P19 cell population, the cyclin D1–CDK4 complex is detected, which is replaced by cyclin D2/3–CDK4/6–p27 complex following density arrest. During endodermal differentiation kinase‐inactive cyclin D2/D3–CDK4–p27 complexes are formed. Neural differentiation specifically induces cyclin D1 at the expense of cyclin D3 and results in predominant formation of cyclin D1/D2–CDK4–p27 complexes. Differentiation is accompanied by cytoplasmic accumulation of cyclin Ds and CDK4/6, which in neural cells are associated with neural outgrowths. Most phenomena found here can be reproduced in mouse embryonic stem cells. In summary, our data demonstrate (i) that individual cyclin D isoforms are utilized in cells lineage specifically, (ii) that fundamental difference in the function of CDK4 and CDK6 exists, and (iii) that cyclin D–CDK4/6 complexes function in the cytoplasm of differentiated cells. Our study unravels another level of complexity in G1/S transition‐regulating machinery in early embryonic cells.
Collapse
Affiliation(s)
- V Bryja
- Institute of Biophysics, Academy of Sciences of the Czech Republic, Brno, Czech Republic,Institute of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic,Center for Cell Therapy and Tissue Repair, Charles University, Prague, Czech Republic,Department of Molecular Embryology, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Prague, Czech Republic, andDepartment of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
| | - J Pacherník
- Institute of Biophysics, Academy of Sciences of the Czech Republic, Brno, Czech Republic,Institute of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic,Center for Cell Therapy and Tissue Repair, Charles University, Prague, Czech Republic,Department of Molecular Embryology, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Prague, Czech Republic, andDepartment of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
| | - J Vondráček
- Institute of Biophysics, Academy of Sciences of the Czech Republic, Brno, Czech Republic,Institute of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic,Center for Cell Therapy and Tissue Repair, Charles University, Prague, Czech Republic,Department of Molecular Embryology, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Prague, Czech Republic, andDepartment of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
| | - K Souček
- Institute of Biophysics, Academy of Sciences of the Czech Republic, Brno, Czech Republic,Institute of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic,Center for Cell Therapy and Tissue Repair, Charles University, Prague, Czech Republic,Department of Molecular Embryology, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Prague, Czech Republic, andDepartment of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
| | - L Čajánek
- Institute of Biophysics, Academy of Sciences of the Czech Republic, Brno, Czech Republic,Institute of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic,Center for Cell Therapy and Tissue Repair, Charles University, Prague, Czech Republic,Department of Molecular Embryology, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Prague, Czech Republic, andDepartment of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
| | - V Horvath
- Institute of Biophysics, Academy of Sciences of the Czech Republic, Brno, Czech Republic,Institute of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic,Center for Cell Therapy and Tissue Repair, Charles University, Prague, Czech Republic,Department of Molecular Embryology, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Prague, Czech Republic, andDepartment of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
| | - Z Holubcová
- Institute of Biophysics, Academy of Sciences of the Czech Republic, Brno, Czech Republic,Institute of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic,Center for Cell Therapy and Tissue Repair, Charles University, Prague, Czech Republic,Department of Molecular Embryology, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Prague, Czech Republic, andDepartment of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
| | - P Dvořák
- Institute of Biophysics, Academy of Sciences of the Czech Republic, Brno, Czech Republic,Institute of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic,Center for Cell Therapy and Tissue Repair, Charles University, Prague, Czech Republic,Department of Molecular Embryology, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Prague, Czech Republic, andDepartment of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
| | - A Hampl
- Institute of Biophysics, Academy of Sciences of the Czech Republic, Brno, Czech Republic,Institute of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic,Center for Cell Therapy and Tissue Repair, Charles University, Prague, Czech Republic,Department of Molecular Embryology, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Prague, Czech Republic, andDepartment of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
| |
Collapse
|
26
|
Tóth B, Pap T, Horvath V, Horvai G. Which molecularly imprinted polymer is better? Anal Chim Acta 2007; 591:17-21. [PMID: 17456419 DOI: 10.1016/j.aca.2007.01.016] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2006] [Revised: 12/22/2006] [Accepted: 01/11/2007] [Indexed: 11/17/2022]
Abstract
Molecularly imprinted polymers (MIP) have been successfully synthesized toward many different compounds in the last decades. The mechanistic details of selective binding at binding sites are not yet well understood. For this reason the characterization of MIP binding has been mostly phenomenological and this makes the transfer of results between different laboratories or between different types of applications difficult. In this paper we analyze the relationship between different types of characterization like isotherms, binding site models, chromatographic k and alpha values, etc. as they relate to different applications like HPLC, solid phase extraction (SPE), binding assays, batch extraction and sensors. It is shown that alpha values determined by elution chromatography depend on seemingly irrelevant factors as the length and diameter of the column, respectively. The determination of distribution ratios or partition coefficients is proposed as an easily understandable and useful quantity in the characterization of novel MIPs. Data used for the characterization of a MIP should be transferable between different applications but the qualification of MIPs as better or worse will depend on the application in case.
Collapse
Affiliation(s)
- B Tóth
- Department of General and Analytical Chemistry, Budapest University of Technology and Economics, Hungary
| | | | | | | |
Collapse
|
27
|
Matthes G, Horvath V, Seifert J, Ptok H, Stengel D, Schmucker U, Ekkernkamp A, Hinz P. Oldie but goldie: Bristow-Latarjet procedure for anterior shoulder instability. J Orthop Surg (Hong Kong) 2007; 15:4-8. [PMID: 17429108 DOI: 10.1177/230949900701500102] [Citation(s) in RCA: 46] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
PURPOSE To analyse the functional and radiological outcomes of the Bristow-Latarjet procedure in patients with recurrent anterior glenohumeral instability. METHODS Records of 29 patients were reviewed retrospectively. Date of first dislocation, injury mechanism, and number of recurring dislocations before and after surgery were recorded. The overall function and stability of the shoulder was evaluated. RESULTS 24 (83%) of the glenohumeral instabilities were caused by trauma. The mean number of recurring dislocations was 8 (95% confidence interval [CI], 0-18); one patient had had 40 recurrences. No dislocation ensued postoperatively. The overall functional outcome was good, with a mean Rowe score of 90 points (95% CI, 78-100). Scores of 17 (59%) of the patients were excellent, 7 (24%) were good, 3 (10%) were fair, and 2 (7%) were poor. CONCLUSION The Bristow-Latarjet procedure is a good surgical treatment for recurrent anterior-inferior instability of the glenohumeral joint.
Collapse
Affiliation(s)
- G Matthes
- Department of Orthopedic and Trauma Surgery, Ernst-Moritz-Arndt-University Greifswald, Greifswald, Germany.
| | | | | | | | | | | | | | | |
Collapse
|
28
|
Tóth B, Pap T, Horvath V, Horvai G. Nonlinear adsorption isotherm as a tool for understanding and characterizing molecularly imprinted polymers. J Chromatogr A 2005; 1119:29-33. [PMID: 16300772 DOI: 10.1016/j.chroma.2005.10.048] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2005] [Revised: 09/19/2005] [Accepted: 10/18/2005] [Indexed: 10/25/2022]
Abstract
Molecularly imprinted polymers (MIPs) have frequently been characterized by quantities which are easily determined from experiments but have no theoretical foundation. This makes it difficult to compare different MIP preparations or to transfer MIP based methods to different experimental conditions. Since the adsorption isotherms of MIPs are markedly nonlinear, one can build a better characterization strategy on isotherms as shown by examples in this paper.
Collapse
Affiliation(s)
- B Tóth
- Department of General and Analytical Chemistry, Budapest University of Technology and Economics, Budapest, Hungary
| | | | | | | |
Collapse
|
29
|
Bryja V, Pacherník J, Soucek K, Horvath V, Dvorák P, Hampl A. Increased apoptosis in differentiating p27-deficient mouse embryonic stem cells. Cell Mol Life Sci 2004; 61:1384-400. [PMID: 15170516 DOI: 10.1007/s00018-004-4081-4] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Abstract
In mouse embryonic stem (mES) cells, the expression of p27 is elevated when differentiation is induced. Using mES cells lacking p27 we tested the importance of p27 for the regulation of three critical cellular processes: proliferation, differentiation, and apoptosis. Although cell cycle distribution, DNA synthesis, and the activity of key G1/S-regulating cyclin-dependent kinases remained unaltered in p27-deficient ES cells during retinoic acid-induced differentiation, the amounts of cyclin D2 and D3 in such cells were much lower compared with normal mES cells. The onset of differentiation induces apoptosis in p27-deficient cells, the extent of which can be reduced by artificially increasing the level of cyclin D3. We suggest that the role of p27 in at least some differentiation pathways of mES cells is to prevent apoptosis, and that it is not involved in slowing cell cycle progression. We also propose that the pro-survival function of p27 is realized via regulation of metabolism of D-type cyclin(s).
Collapse
Affiliation(s)
- V Bryja
- Center for Cell Therapy and Tissue Repair, Charles University, V Uvalu 84, 150 06 Prague, Czech Republic
| | | | | | | | | | | |
Collapse
|
30
|
Leypold J, Kriz Z, Privara M, Horvath V, Dvorak M. [Assessment of functional capability of liver parenchyma using indocyanine green before liver resection]. BRATISL MED J 2001; 102:115-6. [PMID: 11396123] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/20/2023]
Abstract
During the period from 1997 to 2000, the total of 129 liver operations were performed at the 2nd Surgical Department of the Masaryk's University in Brno. Malignant tumours were present in 91 cases. In-hospital mortality in patients operated on for malignant liver tumours was 2.1%. No case of death was caused by liver insufficiency. Examination of liver function by use of indocyanine green (ICG) enabling the determination of the extent of possible resection, contributes to the lowering of postoperative morbidity and mortality. The rate of indocyanine green retention up to 6% does not limit the extent of resection, the retention rate up to 15% allows bisegmentectomy or a minor surgery, the retention rate up to 20% allows segmentectomy at the most, and the retention rate up to 30% enables superficial excisions only.
Collapse
Affiliation(s)
- J Leypold
- II. chirurgická klinika LFMU, FN u sv. Anny, Pekarská 53, CZ-656 91 Brno.
| | | | | | | | | |
Collapse
|
31
|
Horvath V, Bakhshandeh A, Hartlapp J, Hegewisch-Becker S, Feyerabend T, Fischer v. Weikersthal L, Illiger H, Jäger E, Peters S, Reichardt P, Uthgenannt D, Weber D, Wagner T, Wiedemann G, Zschaber R. Oral Trofosfamide in Elderly and/or Heavily Pretreated Patients with Metastatic Lung Cancer. Oncol Res Treat 2000. [DOI: 10.1159/000027167] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
32
|
Sefton M, Uludag H, Babensee J, Roberts T, Horvath V, De Boni U. Microencapsulation of Cells in Thermoplastic Copolymer (Hydroxyethyl Methacrylate–Methyl Methacrylate). Methods in Neurosciences 1994. [DOI: 10.1016/b978-0-12-185291-7.50028-x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
|
33
|
Yap WT, Locascio-Brown L, Plant AL, Choquette SJ, Horvath V, Durst RA. Liposome flow injection immunoassay: model calculations of competitive immunoreactions involving univalent and multivalent ligands. Anal Chem 1991; 63:2007-11. [PMID: 1750702 DOI: 10.1021/ac00018a020] [Citation(s) in RCA: 25] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
The use of liposomes as detectable reagents in solid-phase immunoassays has been explored in a flow injection immunoanalysis (FIIA) system. Model calculations are presented for FIIA based on the competitive binding of univalent analyte and multivalent liposomes to immobilized antibodies. Parameters such as binding constants, concentrations of liposomes and antibody, and steric hindrance are considered for their relative effects on detectable liposome signal response to analyte concentrations. Qualitative comparisons of the model with the experimental data are made.
Collapse
Affiliation(s)
- W T Yap
- Center for Analytical Chemistry, NIST, Gaithersburg, Maryland 20899
| | | | | | | | | | | |
Collapse
|
34
|
Abstract
A diffusion-based insulin micropump was capable of sustaining normoglycemia in diabetic, pancreatectomized dogs for as long as 10 months. Basal insulin delivery was provided by diffusion into the peritoneal cavity from the insulin reservoir across a silicone rubber porous outlet, while the delivery of insulin was augmented for 35 minutes at mealtimes by repeated squeezing of a polyurethane foam disk; the latter was initiated 15 minutes prior to the start of the meal. In the best implant, which functioned for more than 10 months before it was deliberately terminated, the mean glucose level was 126 +/- 24.7 mg/dl (+/- SD) and the mean Schlichtkrull M value was 2.8. In the other three implants, the mean and standard deviations were a little higher. The basal insulin supply was sufficient to restore normoglycemia each morning, while the augmented supply substantially reduced the size of the postprandial period of hyperglycemia. Over the 10 month period studied, the maximum concentration was 150 mg/dl approximately 6 hours after the beginning of the meal, based on the mean of the approximately 200 glucose profiles determined for this implant. Despite this ability to maintain reasonable normoglycemic profiles for long periods, the pump performance deteriorated over this time period, presumably from a tissue reaction to the porous outlet of the implant. This deterioration was evident in the higher levels of glycemia associated with an insulin delivery program that was maintained for too long or in the need to readjust the program to achieve similar levels of glycemia. Nevertheless, the biocompatibility and efficacy of the controlled release micropump demonstrates the feasibility of this approach.
Collapse
Affiliation(s)
- V Horvath
- Department of Chemical Engineering and Applied Chemistry, University of Toronto, Ontario
| | | | | |
Collapse
|